CARLSBAD, Calif., May 26, 2021 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will present a company overview at the following virtual investor conferences:

(PRNewsfoto/Ionis Pharmaceuticals, Inc.)

  • William Blair 41st Annual Growth Stock Conference on Tuesday, June 1, 2021
  • Goldman Sachs 42nd Annual Global Healthcare Conference on Wednesday, June 9, 2021
  • Nasdaq 44th Investor Conference on Tuesday, June 15, 2021
  • BMO Biopharma Day: Spotlight on Rare Disease and Ophthalmology on Tuesday, June 22, 2021

The above listed dates are subject to change. Details on presentation times or changes to presentation dates can be found on the Company's website. Please check www.ionispharma.com for the latest information.

A live webcast of the presentations will be available on the Investors & Media section of the Ionis website. The replays will be available within 48 hours and will be archived for a limited time.

About Ionis Pharmaceuticals
For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry-leading neurological and cardiometabolic franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision of becoming one of the most successful biotechnology companies.

To learn more about Ionis visit www.ionispharma.com and follow us on Twitter @ionispharma.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/ionis-to-present-at-upcoming-investor-conferences-301299234.html

SOURCE Ionis Pharmaceuticals, Inc.

Copyright 2021 PR Newswire

Ionis Pharmaceuticals (NASDAQ:IONS)
Historical Stock Chart
From Aug 2021 to Sep 2021 Click Here for more Ionis Pharmaceuticals Charts.
Ionis Pharmaceuticals (NASDAQ:IONS)
Historical Stock Chart
From Sep 2020 to Sep 2021 Click Here for more Ionis Pharmaceuticals Charts.